09/02/2017

Kaiku® Health expands rapidly to European cancer centers

Cancer centers in Naples, Nuremberg and Furth have applied Netmedi’s Kaiku® Health –platform for the electronic follow-up of the cancer treatments and patients’ quality of life. In Sweden, Kaiku® Health is used in a national research project coordinated from Gothenburg.

One of the leading immunotherapy centers in the world selected Kaiku® Health for systematic follow-up of patients treated with immune checkpoint inhibitors.

“The adverse event profile of immunotherapy differs from conventional oncological treatments. Thus, it sets new requirements for patient follow-up. Kaiku® Health is a system which allows us to detect and treat the symptoms early on,” explains Professor Paulo A. Ascierto, Director at National Tumor Institute Fondazione G. Pascale, Naples, Italy.

In Germany, Kaiku® Health is implemented for electronic patient follow-up at two new cancer clinics located in Nuremberg and Fürth. In Sweden, Kaiku® Health –platform is used for digital collection of research data in a national phase 4 clinical trial coordinated from Gothenburg.

“Our digital platform has already supported the healthcare of over 20 000 people globally. These new European clients are further accelerating our international growth during 2017 and beyond. Kaiku Health will be supporting a rapidly growing number of patients and their quality of lives,” says Lauri Sippola, CEO and Co-founder of Netmedi Ltd.

About Kaiku® Health

Kaiku® Health web application asks the right questions from the patient at the right time according to the therapy phase, provides advice and enables secure communication online with the care team. Consistent follow-up of adverse events and patients’ quality of life ensure that the care team stays up-to-date on their patient’s health status. With Kaiku® Health, the cancer centers and researchers get ten times more relevant data on the treatment outcomes. Kaiku® Health supports several treatment options of all common cancer types. Over 20 clinics and institutes in Switzerland, Germany, Italy, Sweden and Finland have integrated Kaiku® Health to their workflow. Kaiku® Health is developed by Finnish health technology company Netmedi Ltd. Visit www.kaikuhealth.com for patient stories and client references.

For more information, please contact

Lauri Sippola
CEO
+358 40 744 7481
lauri.sippola@netmedi.fi

Attachments
Press_Kaiku®-Health-expands-rapidly-to-European-cancer-centers.pdf
PDF Press Release Kaiku Health expands rapidly to Europe

← Back to press